Renal and hemodynamic effects of dapagliflozin in recently hospitalized patients with heart failure with mildly reduced or preserved ejection fraction in DELIVER

被引:0
|
作者
Chatur, Safia [1 ]
Cunningham, J. W. [1 ]
Vaduganathan, M. [1 ]
Claggett, B. [1 ]
Desai, A. S. [1 ]
Jhund, P. S. [2 ]
De Boer, R. A. [3 ]
Hernandez, A. F. [4 ]
Inzucchi, S. E. [5 ]
Kosiborod, M. N. [6 ]
Lam, C. S. P. [7 ]
Martinez, F. A. [8 ]
Shah, S. J. [9 ]
Mc Murray, J. J. V. [2 ]
Solomon, S. D. [1 ]
机构
[1] Harvard Med Sch, Brigham & Womens Hosp, Boston, MA 02115 USA
[2] BHF Glasgow Cardiovasc Res Ctr, Glasgow, Lanark, Scotland
[3] Univ Med Ctr Groningen, Groningen, Netherlands
[4] Duke Univ, Med Ctr, Durham, NC USA
[5] Yale Sch Med, New Haven, CT USA
[6] St Lukes Mid Amer Heart Inst, Kansas City, MO USA
[7] Natl Heart Ctr Singapore, Singapore, Singapore
[8] Univ Nacl Cordoba, Cordoba, Argentina
[9] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:38 / 39
页数:2
相关论文
共 50 条
  • [41] The cost-effectiveness of dapagliflozin in heart failure with preserved or mildly reduced ejection fraction: a European health-economic analysis of the DELIVER trial
    Booth, David
    Davis, Jason A.
    McEwan, Phil
    Solomon, Scott D.
    McMurray, John J. V.
    De Boer, Rudolf A.
    Comin-Colet, Josep
    Bachus, Erasmus
    Chen, Jieling
    EUROPEAN JOURNAL OF HEART FAILURE, 2023, 25 (08) : 1386 - 1395
  • [42] Microvascular Complications of Type 2 Diabetes in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction in the DELIVER Trial
    Presslie, Calum
    Yang, Mingming
    Desai, Akshay S.
    Claggett, Brian
    Vaduganathan, Muthiah
    De Boer, Rudolf A.
    Hernandez, Adrian F.
    Inzucchi, Silvio E.
    Kosiborod, Mikhail N.
    Lam, Carolyn S.
    Martinez, Felipe
    Shah, Sanjiv J.
    Petersson, Magnus
    Langkilde, Anna Maria
    Solomon, Scott D.
    McMurray, John J.
    Jhund, Pardeep S.
    CIRCULATION, 2023, 148
  • [43] Initial Decline in Estimated Glomerular Filtration Rate After Initiation of Dapagliflozin in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction: Insights From DELIVER
    Mc Causland, Finnian R.
    Claggett, Brian
    Vaduganathan, Muthiah
    Desai, Akshay S.
    Jhund, Pardeep S.
    Vardeny, Orly
    Fang, James C.
    de Boer, Rudolf A.
    Docherty, Kieran
    Hernandez, Adrian F.
    Inzucchi, Silvio E.
    Kosiborod, Mikhail N.
    Lam, Carolyn S.
    Martinez, Felipe
    Saraiva, Jose F.
    McGrath, Martina
    Shah, Sanjiv J.
    Verma, Subodh
    Langkilde, Anna Maria
    Petersson, Magnus
    CIRCULATION, 2023, 148
  • [44] Breakthroughs in the treatment of heart failure with mildly reduced and preserved ejection fraction
    Talha, Khawaja M.
    Butler, Javed
    CLINICAL CARDIOLOGY, 2022, 45 : S31 - S39
  • [45] Dapagliflozin in Heart Failure with Preserved Ejection Fraction
    Zweck, Elric
    Westenfeld, Ralf
    Redfors, Bjorn
    Omerovic, Elmir
    Weir, Robin A. P.
    Gabrielli, Domenico
    Oliva, Fabrizio
    Zuccala, Giuseppe
    Solomon, Scott D.
    Vaduganathan, Muthiah
    McMurray, John J. V.
    NEW ENGLAND JOURNAL OF MEDICINE, 2023, 388 (03): : 286 - 286
  • [46] Implementation Approaches in Heart Failure With Mildly Reduced and Preserved Ejection Fraction
    Bhatt, Ankeet S.
    Filippatos, Gerasimos
    Vaduganathan, Muthiah
    JACC-HEART FAILURE, 2024, 12 (04) : 628 - 630
  • [47] Dapagliflozin in patients with heart failure and reduced ejection fraction
    Giorgio Colombo
    Rosa Casella
    Alessia Cazzaniga
    Chiara Casiraghi
    Internal and Emergency Medicine, 2020, 15 : 515 - 517
  • [48] Dapagliflozin in patients with heart failure and reduced ejection fraction
    Colombo, Giorgio
    Casella, Rosa
    Cazzaniga, Alessia
    Casiraghi, Chiara
    INTERNAL AND EMERGENCY MEDICINE, 2020, 15 (03) : 515 - 517
  • [49] Cost-utility analysis of add-on dapagliflozin in heart failure with preserved or mildly reduced ejection fraction
    Tang, Yi
    Sang, Haiqiang
    ESC HEART FAILURE, 2023, 10 (04): : 2524 - 2533
  • [50] Dapagliflozin for patients with heart failure and reduced ejection fraction
    Ferry, Abigail
    JAAPA-JOURNAL OF THE AMERICAN ACADEMY OF PHYSICIAN ASSISTANTS, 2022, 35 (09): : 51 - 53